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A B S T R A C T
Objective: To compare the performance of diﬀerent methods for determining hippocampal atrophy rates using
longitudinal MRI scans in aging and Alzheimer's disease (AD).
Background: Quantifying hippocampal atrophy caused by neurodegenerative diseases is important to follow the
course of the disease. In dementia, the eﬃcacy of new therapies can be partially assessed by measuring their
eﬀect on hippocampal atrophy. In radiotherapy, the quantiﬁcation of radiation-induced hippocampal volume
loss is of interest to quantify radiation damage. We evaluated plausibility, reproducibility and sensitivity of eight
commonly used methods to determine hippocampal atrophy rates using test-retest scans.
Materials and methods: Manual, FSL-FIRST, FreeSurfer, multi-atlas segmentation (MALF) and non-linear regis-
tration methods (Elastix, NiftyReg, ANTs and MIRTK) were used to determine hippocampal atrophy rates on
longitudinal T1-weighted MRI from the ADNI database. Appropriate parameters for the non-linear registration
methods were determined using a small training dataset (N=16) in which two-year hippocampal atrophy was
measured using test-retest scans of 8 subjects with low and 8 subjects with high atrophy rates. On a larger dataset
of 20 controls, 40 mild cognitive impairment (MCI) and 20 AD patients, one-year hippocampal atrophy rates
were measured. A repeated measures ANOVA analysis was performed to determine diﬀerences between controls,
MCI and AD patients. For each method we calculated eﬀect sizes and the required sample sizes to detect one-year
volume change between controls and MCI (NCTRL_MCI) and between controls and AD (NCTRL_AD). Finally, re-
producibility of hippocampal atrophy rates was assessed using within-session rescans and expressed as an
average distance measure DAve, which expresses the diﬀerence in atrophy rate, averaged over all subjects. The
same DAve was used to determine the agreement between diﬀerent methods.
Results: Except for MALF, all methods detected a signiﬁcant group diﬀerence between CTRL and AD, but none
could ﬁnd a signiﬁcant diﬀerence between the CTRL and MCI. FreeSurfer and MIRTK required the lowest sample
sizes (FreeSurfer: NCTRL_MCI= 115, NCTRL_AD=17 with DAve= 3.26%; MIRTK: NCTRL_MCI= 97, NCTRL_AD= 11
with DAve= 3.76%), while ANTs was most reproducible (NCTRL_MCI= 162, NCTRL_AD= 37 with DAve= 1.06%),
followed by Elastix (NCTRL_MCI= 226, NCTRL_AD=15 with DAve= 1.78%) and NiftyReg (NCTRL_MCI= 193,
NCTRL_AD=14 with DAve= 2.11%). Manually measured hippocampal atrophy rates required largest sample sizes
to detect volume change and were poorly reproduced (NCTRL_MCI= 452, NCTRL_AD= 87 with DAve= 12.39%).
Atrophy rates of non-linear registration methods also agreed best with each other.
Discussion and conclusion: Non-linear registration methods were most consistent in determining hippocampal
atrophy and because of their better reproducibility, methods, such as ANTs, Elastix and NiftyReg, are preferred
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for determining hippocampal atrophy rates on longitudinal MRI. Since performances of non-linear registration
methods are well comparable, the preferred method would mostly depend on computational eﬃciency.
1. Introduction
The hippocampus is a small cortical structure that plays an im-
portant role in memory formation. In many neurodegenerative diseases
it is impaired due to progressive degeneration and/or death of nerve
cells which is reﬂected in a decrease in hippocampal volume.
Hippocampal atrophy has been extensively studied in Alzheimer's dis-
ease (AD), where neurodegeneration leads to structural brain changes
visible on MRI. Hippocampal atrophy is typically determined by deli-
neating the hippocampus (manually or automatically) on longitudinal
MRI scans.
Hippocampal volume and volume change have been studied ex-
tensively. For instance, hippocampal atrophy has been reported to be
larger in AD compared to mild cognitive impairment (MCI) or healthy
controls [Apostolova and Thomson, 2009; Henneman et al., 2009;
Likeman et al., 2005; Mouiha and Duchesne, 2011; Sabuncu, 2011;
Schuﬀ et al., 2009]. In clinical trials, in which disease-modifying
therapies are studied, hippocampal atrophy is an important biomarker
to provide evidence of treatment eﬀect and to better understand its
underlying mechanism. Completed clinical trials in which hippocampal
atrophy is an outcome measure are reviewed in [Cash et al., 2014].
Recently, there has also been an interest in investigating hippo-
campal damage after radiotherapy. Animal studies have shown that the
neural stem cell (NSC) compartment in the dentate gyrus of the hip-
pocampus is vulnerable to radiation toxicity and already small doses
can damage the NSC [Ferrer et al., 1993; Madsen et al., 2003;
Mizumatsu et al., 2003; Nagai et al., 2000; Raber et al., 2004]. Often, in
patients with brain tumours or brain metastases brain radiation therapy
is the core treatment [Makale et al., 2016]. Furthermore, in patients
with small cell lung cancer (SCLC) prophylactic cranial irradiation (PCI)
is used to treat microscopic brain disease that is statistically likely to be
present, and to reduce the risk of developing larger metastases [Gondi
et al., 2010; Péchoux et al., 2016]. The magnitude of hippocampal
volume loss due to PCI or other brain radiation treatment techniques is
currently unknown. For this reason, it is important to assess and com-
pare the sensitivity of currently available processing techniques to de-
tect volume diﬀerences in hippocampal volume from longitudinal MRI.
The hippocampus has limited contrast on MR images because ad-
jacent structures have similar intensities [Fischl et al., 2002] and
therefore manual delineation is labour intensive and diﬃcult even for
experienced observers. Furthermore, this lack of contrast also is an
important source of intra- and inter-observer variability. Measuring
hippocampal atrophy rates on longitudinal MRI scans is even more
challenging, because in segmentations performed on multiple time-
points the volume errors add up, whereas the volume change is small.
This was shown by [Mulder et al., 2014], in which manually measured
atrophy rates were not well reproduced using longitudinal data with
within-session rescans. To avoid the burden of manual labour and to
reduce observer variability, automatic segmentation methods have
been proposed, most of them reviewed in [Dill et al., 2015] and
[González-Villà et al., 2016]. For instance, FSL-FIRST [Patenaude et al.,
2011] and FreeSurfer [Fischl et al., 2002; Reuter et al., 2012] are au-
tomatic segmentation methods which are used extensively in the aca-
demic community. Both methods were investigated in a longitudinal
setting in [Mulder et al., 2014] and both showed similarly poor atrophy
reproducibility rates. More recently, multi-atlas registration methods
were introduced and showed high overlap with manual segmentations
[Wang et al., 2013; Zhu et al., 2017] and outperformed FSL-FIRST or
FreeSurfer [Pipitone et al., 2014], but these can require long compu-
tation times.
An alternative for dedicated longitudinal segmentation methods and
multi-atlas registration techniques is to use general purpose non-linear
registration algorithms that map a (manual or automatic) segmentation
of a baseline (BL) image to a follow up (FU) image. In the presence of
MCI and AD, hippocampal atrophy rates have been measured pre-
viously using non-linear registration [Crum et al., 2001; Henneman
et al., 2009; van de Pol et al., 2007a]. In these studies, atrophy rates
measured on the basis of non-linear registration showed improved re-
liability compared to manually measured atrophy rates and sig-
niﬁcantly diﬀerent hippocampal atrophy rates between healthy con-
trols, MCI and AD were found. Hippocampal atrophy rates have been
measured using symmetric non-linear registration [Yushkevich et al.,
2010] and [Das et al., 2012], which yielded higher sensitivity than a
semi-automatic segmentation method [Yushkevich et al., 2010]. Sym-
metric non-linear registration methods are not susceptible to directional
registration bias and are therefore the preferred registration scheme for
robust and sensitive longitudinal analysis. A symmetric registration
procedure is for instance also used in FreeSurfer's longitudinal pipeline
[Reuter et al., 2010; Reuter et al., 2012; Reuter and Fischl, 2011].
In this study, we compared hippocampal atrophy measurements
using eight diﬀerent methods: manual segmentation, automatic seg-
mentation (FreeSurfer v6.0, FSL-FIRST v5.0.10, multi-atlas segmenta-
tion with joint label fusion (MALF, [Wang et al., 2013])), and four
symmetric non-linear registration methods (Elastix [Klein et al., 2010;
Shamonin et al., 2013], NiftyReg [Modat et al., 2010; Modat et al.,
2012], Medical Image Registration ToolKit (MIRTK) [Schuh et al.,
2014] and the diﬀeomorphic registration method from the Advanced
Normalization Tools (ANTs, http://stnava.github.io/ANTs/) referred to
as Symmetric Normalization (SyN) [Avants et al., 2008]). We chose
these registration methods because they are publically available and
have been frequently used in the academic community. Furthermore,
ANTs and MIRTK scored high in a study in which 14 non-linear regis-
tration methods were compared [Klein et al., 2009].
The aim of this study was to determine the accuracy of methods to
measure subtle hippocampal volume change on the basis of plausibility
(does the method show atrophy where biologically expected?), re-
producibility (does the method provide the same atrophy rates for
within-session rescans of the same subject?) and sensitivity (how many
subjects are required to detect a signiﬁcant group diﬀerence?).
Therefore, we measured atrophy rates in diﬀerent diagnostic groups
(controls, MCI and AD) and performed an atrophy rate reproducibility
analysis.
2. Materials and methods
2.1. Datasets and image acquisition
In this study we determined hippocampal volume change on two
diﬀerent datasets from the Alzheimer's Disease Neuroimaging Initiative
(ADNI) database. Both datasets are described below. The ADNI was
launched in 2003 as a public-private partnership, led by Principal
Investigator Michael W. Weiner, MD. The primary goal of ADNI has
been to test whether serial magnetic resonance imaging (MRI), positron
emission tomography (PET), other biological markers, and clinical and
neuropsychological assessment can be combined to measure the pro-
gression of mild cognitive impairment (MCI) and early Alzheimer's
disease (AD).
2.1.1. Training dataset
Training data consisted of a small subset (N=16) of the ADNI data
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base in which MCI subjects were recorded at BL and at FU two years
later. The same data set was previously used and described in more
detail in [Nho et al., 2013]. These data were used to tune parameter
settings for each non-linear registration method.
At each time-point, two sagittal 3D T1 weighted magnetization
prepared rapid acquisition gradient echo sequence (MPRAGE) 1.5 T
MRI were acquired in a single session, just a few seconds apart from
each other. In the remainder of this paper we use the term “A and B
scans” for those back-to-back (BTB) scan pairs. As described in [Nho
et al., 2013], an extreme-trait design was used, where participants were
selected at the extremes of the 2-year longitudinal change distribution
of hippocampal volume (eight participants with fast rates of atrophy
and eight with slow rates of atrophy). The MRI acquisition is explained
in more detail in [Jack et al., 2008]. “Gold standard” manual hippo-
campus segmentations were not available for this dataset. The magni-
tude of the rate of hippocampal volume change was not reported, but
groups (slow and fast) diﬀered in the rate of change (p < 0.001) de-
termined by the statistical parametric mapping (SPM) software package
(http://www.ﬁl.ion.ucl.ac.uk/spm/).
2.1.2. Validation dataset
This dataset is the same dataset as used by [Mulder et al., 2014] and
[Bartel et al., 2017]. Eighty subjects were collected from ADNI in-
cluding 20 healthy controls (CTRL), 40 MCI and 20 AD subjects. MCI
patients were selected based on their CSF proﬁle, using an AD-positive
cut-oﬀ values of tau/Aβ1–42≥ 0.39 determined by (Shaw et al., 2009).
In (Mulder et al., 2014) two subgroups of MCI patients were a priori
selected, 20 MCI patients with an AD-positive CSF proﬁle, and 20 MCI
patients with an AD-negative proﬁle (tau/Aβ1–42 < 0.39). In the pre-
sent article, for simplicity those subgroups were merged. Subjects in the
CTRL group all had a tau/Aβ1–42 value of< 0.39. In the AD group, all
but one subject had a tau/Aβ1–42 value of≥0.39. The subjects included
in the original study (Mulder et al., 2014) were not selected to sample
the distribution of disease durations in a systematic fashion or in a
fashion representative of the full ADNI cohort and therefore, these data
do not allow an investigation of the relation between performance of
methods and disease duration. More information about the subjects'
demographics is presented in (Mulder et al., 2014). BL and FU scans
were obtained one year apart and similarly as for the training dataset
BTB scans (A and B scans) were acquired with the same imaging se-
quence within a single session. The MRI acquisition is explained in
[Jack et al., 2008].
2.2. Hippocampus segmentation
2.2.1. Manual hippocampus segmentation (only validation dataset)
For the ADNI dataset, hippocampi were segmented at the VU
University Medical Center (VUmc) Amsterdam) using the outlining
protocol from [Jack, 1994], described in [Jack, 1994; Mulder et al.,
2014; van de Pol et al., 2007b]. All BL MRI scans were reformatted
perpendicularly to the long axis of the hippocampus with a slice
thickness of 2mm, while the in-plane resolution was kept. The M12
scans were then rigidly registered to the BL scans. For hippocampus
segmentation on the M12 scans, BL scans and hippocampus segmen-
tations were shown next to the M12 scans. However, to avoid any
training eﬀect the observer (N=1) obtained A and B scans in a random
order and did not know the diagnosis. The observer was a well-trained
expert of the VUmc and used in-house developed software (Show_I-
mages 3.7.1.0) for hippocampus segmentation.
2.2.2. FSL v.5.0.10 (both datasets)
FSL-FIRST hippocampus segmentation is described in detail in
[Patenaude, 2007] and [Patenaude et al., 2011]. It uses shape and
appearance models created from a set of manual hippocampus seg-
mentations from the Center for Morphometric Analysis (CMA), Massa-
chusetts General Hospital (MGH) Boston. The manual segmentations
were converted to parameterized surface meshes using intensity values
around the tissue border and from these a point distribution model was
created. For hippocampus segmentation the MRI is registered to
MNI152 standard space using a two-stage aﬃne registration. Then, FSL-
FIRST searches through linear combinations of shape variation modes
to ﬁnd the most probable shape by using the intensity values of the
MRI. The hippocampal mesh is then converted to a voxel-wise seg-
mentation using FAST [Zhang et al., 2001]. For both datasets, we used
the run_ﬁrst_all command without pre-processing the images.
2.2.3. FreeSurfer v.6.0 (only validation dataset)
FreeSurfer subcortical segmentation is described in detail in [Fischl
et al., 2002]. FreeSurfer converts MRI scans to their own conformed
1mm3 2563 space, performs a bias-ﬁeld correction, intensity normal-
ization and skull-stripping for an atlas registration. Using prior intensity
and tissue class information, voxels are assigned to subcortical struc-
tures. We used FreeSurfer's longitudinal stream to determine hippo-
campal volumes [Reuter et al., 2010; Reuter et al., 2012; Reuter and
Fischl, 2011], which includes an unbiased registration procedure and a
label fusion technique. FreeSurfer's longitudinal pipeline was in-
troduced in 2007 (FreeSurfer v4.0.0) and since then FreeSurfer has
undergone several improvements. We used FreeSurfer v.6.0 released in
2017. In this study, FreeSurfer's default parameters have not been
changed and therefore FreeSurfer was only applied on the validation
dataset.
2.2.4. Multi-atlas label fusion segmentation (both datasets)
We used the multi-atlas joint label fusion (MALF) segmentation
described in [Wang et al., 2013], implemented in the ANTs software
[Avants et al., 2014]. Brieﬂy, using non-linear registration a set of
segmented atlases is deformed to a target image and all transformed
atlases are combined to one label using a joint label fusion technique
[Wang et al., 2013]. To speed up registration time we used a registra-
tion scheme provided by the ANTs software (antsRegis-
trationSyNQuick.sh [Avants et al., 2012; Tustison and Avants, 2013]),
which uses a mutual information metric. Twenty atlases were used as
input for MALF (9CTRL, 8MCI, 3AD). The segmentation ﬁles and MRI
were obtained from the Harmonized Protocol for Hippocampal Seg-
mentation (HarP) project's website (http://www.hippocampal-
protocol.net/). HarP is a standardized hippocampus outlining pro-
tocol in which hippocampal boundary deﬁnitions from diﬀerent out-
lining protocols were merged [Boccardi et al., 2011; Boccardi et al.,
2015; Frisoni et al., 2015].
2.2.5. Non-linear registration methods (both datasets)
As input to non-linear registration, a rigid 6 degree of freedom
(DOF) registration was provided that maps the FU scan to the corre-
sponding BL scan. These registrations were all performed using FLIRT
from the FSL toolbox [Jenkinson et al., 2002; Jenkinson and Smith,
2001]. Furthermore, brain masks were used for source and target image
that were obtained by applying FSL's brain extraction tool (BET) on all
subjects' MRI scans. Four symmetric non-linear registration methods
were used:
1. Elastix v4.801 [Klein et al., 2010; Shamonin et al., 2013]
2. NiftyReg v1.4.0 [Modat et al., 2010; Modat et al., 2012]
3. Medical image registration toolkit (MIRTK, compiled from the git
development tree https://github.com/schuhschuh/MIRTK/tree/
develop rev daf2b89, built on Dec 192,017) [Schuh et al., 2014]
4. Diﬀeomorphic registration method from ANTs v2.2.0, referred to as
symmetric normalization (SyN) [Avants et al., 2008].
ANTs-SyN is a symmetric diﬀeomorphic mapping which guarantees
topology preservation. Elastix, NiftyReg and MIRTK are based on free-
form deformations (FFD) given by the parameters of a cubic B-spline
function [Rueckert et al., 1999]. MIRTK's and NiftyReg's symmetric
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registration schemes are similar in approach using a symmetric energy
formulation to ensure that the transformation is a diﬀeomorphism
[Modat et al., 2012; Schuh et al., 2014]. The symmetric registration
approach for Elastix is described in [Metz et al., 2011]. In this approach
FU scans are resampled to BL scans using rigid registration and spline
interpolation. Then, images were transformed to an average space and
the inverse transformation is approximated as described in [Metz et al.,
2011]. This is diﬀerent to diﬀeomorphic mapping, in which the inverse
is guaranteed to exist. Commands and parameters for each registration
method are presented in the supplementary ﬁles.
2.2.6. Surface reconstruction and mesh deformation
For the validation data set, hippocampi were manually segmented
in cropped MR images, reformatted along the long hippocampal axis.
We performed our analysis using the native MR images and therefore
hippocampus segmentation needed to be mapped back from “segmen-
tation space” to native MRI scan space. To avoid interpolation errors in
this procedure, we converted manual segmentation to meshes using the
marching cube algorithm [Lorensen and Cline, 1987] and applied linear
transformation parameters directly on the meshes. FSL-FIRST, Free-
Surfer and MALF were performed on the native MRIs, but for con-
sistency we also converted the hippocampal segmentations obtained
from these methods to meshes and computed hippocampal volumes
from these meshes.
In the validation set, nonlinearly transformed manual hippocampus
meshes were used to determine longitudinal volume changes and thus
atrophy rates. For the training dataset manual hippocampus segmen-
tations were not available, therefore FSL-FIRST hippocampus segmen-
tations from the BL scans were used to provide the baseline mesh. The
sensitivity of the result to segmentation errors will be estimated below.
2.3. Analysis
Hippocampal volumes were obtained by summing signed tetra-
hedrons created for each triangle in the mesh as described in Cha Zhang
and Tsuhan Chen, 2001. Hippocampal atrophy rates were expressed as
longitudinal percentage volume change (PVC) deﬁned by:
=
−
∗PVC V V V V
V
( , ) 100BL FU FU BL
BL (1)
with VBL and VFU being the volume of the structure from the BL and FU
scans, respectively. We calculated PVC for the left and right hippo-
campus separately, but we averaged them to obtain the subject hip-
pocampal atrophy rates for our analysis. The statistical analysis was
performed with IBM SPSS Statistics for Windows v. 22 Armonk, NY:
IBM Corp. We analysed atrophy diﬀerences between diagnostic groups
and atrophy reproducibility using A and B scans. For our statistical
analysis we reported and excluded all subjects in which hippocampal
PVC was larger than +25% or smaller than −25%, because hippo-
campal atrophy± 25% is an indicator for poor segmentation or regis-
tration and would reduce reliability of the analysis.
2.3.1. Training dataset
For the training dataset “gold standard” manual segmentations were
not available. Instead, FSL-FIRST BL segmentations were mapped to FU
scans with the registration methods. We report two-year PVC in box-
plots to graphically illustrate PVC diﬀerences between methods and
diagnostic groups. In correspondence with the developers of each re-
gistration method we tested diﬀerent registration parameters until we
obtained approximately similar PVC in groups for each method,
knowing that the ‘slow’ group should have less atrophy than the ‘fast’
group [Nho et al., 2013]. Using PVC measurements from the A and B
scans, with repeated measures ANOVA we determined whether there
was a signiﬁcant diﬀerence between the ‘slow’ and the ‘fast’ group
(signiﬁcance level α=0.05), which indicated if registration methods
detected similar atrophy rates.
To be reproducible, the PVCs measured for the A scans should be
approximately the same as for the B scans. To study and quantify re-
producibility, for each method we plotted PVC values from the A scans
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in which n is the number of measured PVC values. These “distances”
can be interpreted as the root mean squared diﬀerence between the A
and B scans.
Furthermore, we performed some consistency checks. A commonly
used method to determine volume change of a non-linear deformation
ﬁeld is integration of the local Jacobian determinants of the ﬁeld. For
comparison, we determined volume changes using Jacobian integra-
tion, which should give very similar results to our mesh-based ap-
proach. Finally, we investigated if PVC values depend on the speciﬁc
choice of the BL segmentation by replacing the FSL-FIRST by the MALF
BL segmentation.
2.3.2. Validation dataset
For the validation dataset we used the registration parameter set-
tings determined with the training set and performed a similar analysis
as for the training dataset. We report one-year PVC in mean, standard
deviations (SD) and boxplots for all methods and diagnostic groups.
Diﬀerences between CTRL, MCI and AD were assessed with repeated
measures ANOVA using Tukey's honestly signiﬁcant diﬀerence (HSD)
post hoc test. Furthermore, we performed a power analysis and esti-
























where μi are the means of the two groups that are compared (CTRL, MCI
or AD). Statistical power (1-β) was set to 80%, signiﬁcance level
α=0.05 using a two-sided alternative hypothesis. Zt is the t-th quantile
of the normal distribution, i.e. zα/2= 1.96 and z1-β=0.8416. We also
presented the atrophy reproducibility measure (DAve, Scans) using A and
B scans' determined PVC values and we used the average distance
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in which n is the number of measured PVC values in the pooled A and B
scans. These “distances” were plotted in a colour coded distance matrix.




Optimized parameter settings can be found in the supplementary
ﬁles. For all methods, the PVC measured was below our set threshold
of± 25%. PVC results obtained with Elastix, NiftyReg, ANTs or MIRTK
of the training data set are shown in Fig. 1, where results have been
separated in ‘slow’ and ‘fast’ groups. Standard deviations of PVC for
pooled A and B measured hippocampal atrophy are presented in
Table 1. Mean and SD PVC for the A and B scans separately can be
found in the supplementary table 1. Despite the low sample size
(N= 16 for each box), median and interquartile ranges overlap well for
all registration methods. The 5% volume loss in two years found by all
methods is in agreement with the annual hippocampal atrophy of ap-
proximately 2.5% found in a meta-analysis by [Tabatabaei-Jafari et al.,
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2015]. All methods showed a similar PVC trend in the ‘slow’ and ‘fast’
group as determined by repeated measures ANOVA (Table 1). ANTs
showed the smallest group diﬀerences, while also having the lowest SD.
In Fig. 2 we plotted hippocampal PVC measured with the A scans
against hippocampal PVC measured with the B scans for the training
dataset. The average distance (DAve) between A and B scans measured
atrophy rates is shown in Table 2. All non-linear registration methods
show a similar reproducibility trend with DAve ranging from 0.86% to
3.08%. ANTs reproduced data best with DAve= 0.86%.
3.1.1. Consistency checks with the training dataset
For all ANTs deformation ﬁelds, we computed the Jacobian de-
terminants and determined hippocampal PVC by integrating local
Jacobian determinants within the region of FSL-FIRST BL hippocampus
segmentations. These PVC values were plotted against the PVC values
obtained by deforming FSL-FIRST hippocampus meshes (supplementary
ﬁg. 1). PVC measured with Jacobian integration was nearly identical to
PVC measured by deforming the meshes (linearly ﬁtted line equation:
y=−0.03+ 1.00*x and a DAve of 0.0027%), illustrating the con-
sistency of the mesh and volume-based methods. BL hippocampus
segmentations were also computed with MALF and converted to me-
shes. Using the ANTs deformation ﬁelds, we deformed MALFs' BL
hippocampal meshes and plotted these hippocampal PVCs against PVCs
obtained by deforming FSL-FIRST BL hippocampal meshes (supple-
mentary ﬁg. 2). Both determinations were highly correlated, with a R2
obtained from a linearly ﬁtted line of 0.915 and a DAve of 0.31%. To
compare FSL-FIRST and MALF BL segmentations were, we calculated
the Jaccard index (Jacc= (A∪B)/(A∩B)) between both BL segmenta-
tions. The mean Jaccard indices for the ‘slow’ and the ‘fast’ groups were
Jaccslow= 0.70(± 0.056) and Jaccfast = 0.73(± 0.029) respectively.
3.1.2. Validation dataset
For the validation dataset, FSL-FIRST's segmentation failed in 35
subjects out of 80, which was surprising because in the training dataset
FSL-FIRST did not fail. To include these cases, we used FSL's brain ex-
traction tool (BET, [Popescu et al., 2012]) to extract the brains of all
subjects and ran FSL-FIRST again. This second FSL-FIRST run still failed
in six subjects. These cases were diﬀerent from the ﬁrst FSL-FIRST run.
To address this incongruity, we included the segmentation ﬁles of these
6 subjects from the ﬁrst FSL-FIRST run for our analysis. In nine subjects,
FSL-FIRST exceeded our set PVC threshold of± 25% in which four
subjects were from the A scans (3 CTRL, 1 AD) and ﬁve from the B scans
(2 CTRL, 1 MCI, 2 AD). For one subjects' A and B scans, MALF and
Elastix also exceeded the± 25% threshold.
Results of PVCs computations are presented in Fig. 3, separated for
the three diagnostic groups and for A and B scans. Corresponding mean
and SDs for pooled A and B scans' PVC are given in Table 3 and mean
PVC for A and B scans separated can be found in the supplementary
table 3. Table 3 also includes results of the repeated measures ANOVA
and post hoc analysis, in which PVCs are compared between diagnostic
groups for each method. Manual, FSL-FIRST and FreeSurfer showed
larger PVC variability compared to the other methods, whereas FSL-
FIRST had largest standard deviations (Table 3). Except for MALF, all
other methods showed a statistically signiﬁcant diﬀerence between
groups using the repeated measures ANOVA. The post hoc analysis for
MALF was therefore irrelevant, but for completeness results are
Fig. 1. Two-year hippocampal PVC determined with four registration methods
for the A and B longitudinal scans. FSL-FIRST BL segmentation was used to
determine PVC with the registration methods. Both groups are subjects with
MCI, one group with ‘slow’ and one with ‘fast’ progressing atrophy. The small
circle are outliers deﬁned by the SPSS software.
Table 1
Mean (μ) and standard deviation (σ) of two-year hippocampal PVC determined
with four registration methods for pooled A and B longitudinal scans. Both
groups are subjects with MCI, one group with ‘slow’ and one with ‘fast’ pro-
gressing atrophy. Using repeated measures ANOVA signiﬁcance between the
‘slow’ and the ‘fast’ group was determined. The F-statistic is the ratio of the
between group variance and the within group variance and the numbers in the
brackets are the degrees of freedom.
Method Slow Fast
μ σ μ σ F(1,30) p-value
Elastix −1.36 2.153 −6.33 5.448 11.82 0.002
NiftyReg −1.96 2.781 −6.24 4.154 12.91 0.001
ANTs −2.39 1.721 −4.66 3.050 7.04 0.013
MIRTK −1.75 2.218 −7.32 6.124 12.26 0.001
Fig. 2. For all four registration methods, hippocampal PVC measured with the
A scans is plotted against hippocampal PVC measured with the B scans. The
dashed line is the identity line. For Elastix and MIRTK there was one subject in
the ‘fast’ group with larger PVC compared to the other cases (two stars corre-
spond to left and right hippocampal PVC). This subject was speciﬁcally high-
lighted (Fast-outlier) to observe if the other methods measured similar high
hippocampal atrophy.
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presented in Table 3. Tukey post hoc analysis revealed that for all
methods there was no signiﬁcant diﬀerence between the CTRL and the
MCI groups. All methods except MALF showed statistically signiﬁcant
higher atrophy rates in the AD group compared to the CTRL group.
Results from our sample size calculation deﬁned in eq. (3) are
presented in Table 4. Because we grouped A and B scans and left and
right hippocampi together, means and the pooled standard deviations
for the sample size calculation were obtained from 80 CTRL, 160 MCI
and 80 AD samples (for FSL-FIRST, Elastix and MALF some outliers
were discarded). Between the CTRL and MCI group FreeSurfer's and
MIRTK's clearly had lowest estimated sample sizes (NCTRL-MCI) with
approximately 30% to 40% less samples required than ANTs, NCTRL-
MCI= 162. For NCTRL-AD FreeSurfer, Elastix, NiftyReg and MIRTK
showed lowest estimated sample sizes with approximately 55% to 70%
less samples required than ANTs estimated sample sizes (NCTRL-
AD= 37). This is about 20% of the number of samples used in this
study.
In Fig. 4, PVC determined using the A scans was plotted against
those based on the B scans. Note that the ﬁgure looks ‘noisier’ than
Fig. 2 because here one-year atrophy rates are used, while the two-years
rate is presented in Fig. 2. Table 5 presents corresponding DAve. ANTs
had lowest DAve (1.06%) followed by Elastix (1.78%) and NiftyReg
(2.11%). Manually determined atrophy rates showed poorest reprodu-
cibility, DAve= 12.39%. Using the same hippocampus segmentations
and MRI scans but a diﬀerent statistical analysis, Mulder and colleagues
observed similarly poor reproducibility based on manual segmentations
[Mulder et al., 2014].
The distance correlation matrix used to visualize overall diﬀerences
between methods is shown in Fig. 5 and the corresponding numerical
average distances in supplementary table 3. These distances show that
atrophy determined manually or with FSL-FIRST correlated poorly with
other methods.
3.1.3. Consistency checks with the validation dataset
PVC values for the non-linear registration methods were determined
by deforming manual BL segmentations (PVCManual_ANTs). To assess
dependency on BL segmentation we also used BL segmentations from
MALF and deformed these with ANTs deformation ﬁelds to obtain new
PVC values (PVCMALF_ANTs). PVCManual_ANTs was plotted against
PVCMALF_ANTs (supplementary ﬁg. 3). The R2 was 0.837 and the average
distance was 0.46%. For the outlier AD cases (red circles in
Table 2
Calculated average distance deﬁned in (2) by using mean and standard devia-
tion of pooled (‘slow’ and ‘fast’) hippocampal PVC. All units are %.
A Scans B Scans
Method μ σ μ σ DAve
Elastix −3.88 5.269 −3.81 4.391 1.93
NiftyReg −3.98 4.373 −4.22 3.913 2.88
ANTs −3.48 2.832 −3.57 2.629 0.86
MIRTK −4.52 5.780 −4.55 5.005 3.08
Fig. 3. One-year hippocampal PVC measured with eight methods for the A and
B longitudinal scans. PVC was determined separately for the CTRL, MCI and AD
groups. The small circle and the star sign are outliers and far outliers deﬁned by
the SPSS software.
Table 3
For all methods mean (μ), standard deviations (σ) of one-year PVC measured on pooled A and B scans are shown. Using repeated measures ANOVA overall group
signiﬁcance was determined and with Tukey's post-hoc analysis in between group diﬀerences were analysed. The F-statistic is the ratio of the between group variance




Method μCTRL σCTRL μMCI σMCI μAD σAD F(2,157) p-value pCTRL-MCI pCTRL-AD
Manual −3.18 3.838 −3.89 3.813 −4.81 3.833 3.15 0.045 0.416 0.036
FSL-FIRST −1.88 3.785 −3.00 4.592 −4.94 4.506 5.59 0.003 0.681 0.005
FreeSurfer −1.42 2.650 −2.53 3.335 −4.47 3.598 10.71 0.000044 0.137 0.000032
MALF −0.86 2.121 −1.60 2.737 −1.88 3.145 2.04 0.134 0.243 0.138
Elastix −1.08 1.480 −1.60 2.359 −2.70 1.665 7.941 0.001 0.262 0.0004
NiftyReg −1.06 1.516 −1.68 2.719 −3.25 2.474 11.02 0.000033 0.301 0.00004
ANTs −2.27 1.798 −2.90 2.216 −3.49 1.941 4.01 0.02 0.215 0.014
MIRTK −1.30 1.752 −2.32 3.133 −3.90 2.599 12.49 0.000009 0.068 0.000006
For FSL-FIRST, Elastix and MALF outliers were removed for the analysis resulting in FFIRST(2145), FElastix(2155), FMALF(2155)
Table 4
Estimated Cohen's d eﬀect size and minimal sample size required to detect
diﬀerence between groups for all methods as deﬁned in Eq. (3). Lowest sample
sizes are highlighted with bold font.
Cohen's d eﬀect size Sample size
Method dCTRL-MCI dCTRL-ADI NCTRL-MCI NCTRL-AD
Manual 0.19 0.42 452 87
FSL-FIRST 0.27 0.74 222 29
FreeSurfer 0.37 0.96 115 17
MALF 0.30 0.38 174 108
Elastix 0.26 1.03 226 15
NiftyReg 0.29 1.07 193 14
ANTs 0.31 0.65 162 37
MIRTK 0.40 1.17 97 11
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supplementary ﬁg. 3), which are further away from the identity line, we
inspected the BL segmentations. MALF BL segmentations slightly
overestimated the hippocampal region and also outlined a small part of
the cerebral ﬂuid next to the hippocampal boundaries. Removing these
cases yielded a R2 of 0.927 and a DAve of 0.26%, illustrating that BL
segmentations are largely interchangeable for computing atrophy rates.
4. Discussion
In this study we compared hippocampal atrophy rates determined
using eight diﬀerent methods and evaluated their diﬀerences based on
plausibility over diagnostic groups, their estimated errors and their
reproducibility over back to back scans. All methods showed largest
PVCs for AD, followed by MCI and controls. The non-linear registration-
based FreeSurfer and MIRTK showed highest sensitivity in terms of
predicted sample size, and ANTs, Elastix and NiftyReg showed largest
reproducibility. The segmentation-based technique FSL-FIRST and
manual segmentations scored lowest in these aspects.
Our atrophy rates reproducibility analysis is in agreement with [van
de Pol et al., 2007a] who used directional non-linear registration
(biased) to measure hippocampal atrophy rates and showed that hip-
pocampal atrophy measured with non-linear registration is more re-
producible than manually measured atrophy. We investigated this with
multiple symmetric non-linear registration (unbiased) methods and
automatic segmentation methods, and we also conclude that hippo-
campal atrophy rates should preferably be computed using such
methods. Using manual segmentation, large sample sizes are needed to
detect diﬀerences between diagnostic groups.
For the validation dataset, FSL-FIRST had several failed segmenta-
tions and MALF was not able to detect hippocampal atrophy rate dif-
ferences between diagnostic groups. For FSL-FIRST, some of the failed
segmentations were caused by poor internal registration results in-
dicating that the procedures might be susceptible to noise. MALF's
poorer performance might be caused by the label fusion, averaging out
the subtle diﬀerences between segmentations.
The ANOVA analysis (Table 3) showed that none of the methods
could ﬁnd a signiﬁcant diﬀerence in hippocampal atrophy between the
CTRL and MCI groups, while the closest was method was MIRTK (p-
value= .068). One possible reason for this could be that we merged
two MCI subgroups together, as described in section 2.1 Validation
dataset. Only selecting MCI subjects with AD-positive cut-oﬀ values
(tau/Aβ1–42≥ 0.39) might result to a clearer diﬀerentiation between
the CTRL and MCI groups. Between CTRLs and AD a signiﬁcant group
Fig. 4. For all eight methods, one-year hippocampal PVC determined with the
longitudinal A scans is plotted against hippocampal PVC determined with the
longitudinal B scans. The dashed line is the identity line.
Table 5
Calculated average distance deﬁned in (2) by using mean and standard devia-
tion of pooled (CTRL, MCI and AD) hippocampal PVC. All units are %.
A Scans B Scans
Method μ σ μ σ DAve
Manual −4.40 4.574 −3.49 2.914 12.39
FSL-FIRST −3.33 4.398 −2.93 3.962 6.15
FreeSurfer −2.92 3.150 −2.56 3.672 3.26
MALF −1.34 2.908 −1.62 2.524 3.60
Elastix −1.79 2.243 −1.64 1.898 1.78
NiftyReg −1.89 2.647 −1.95 2.428 2.11
ANTs −2.84 2.097 −2.93 2.088 1.06
MIRTK −2.62 3.163 −2.30 2.525 3.76
Fig. 5. Using the one-year hippocampal PVC of the validation dataset, the
average “distance” of atrophy rate agreement was calculated using (2) and
plotted in a colour coded matrix. Atrophy measurement methods with lower
distance in PVC (shown in %) have a better correspondence.
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diﬀerence was detected by all methods (MALF excluded).
Except for ANTs, for NCTLR-AD non-linear registration-based methods
resulted in lowest estimated samples sizes. ANTs determined on average
almost 1% more hippocampal atrophy in the CTRL and MCI group
(Table 3), which explains the higher required sample size of NCTLR-
AD= 37. Only looking at the sample size analysis would suggest using
MIRTK or FreeSurfer. We performed the reproducibility analysis to get
a better understanding of the performance and reliability of the
methods. This analysis showed that from the non-linear registration-
based methods the reproducibility rates of MIRTK in the validation
dataset were the worst (DAve= 3.76%) and ANTs reproducibility rates
the best (DAve= 1.06%). Reproducibility of hippocampal atrophy rates
is an important quality measure and because the diﬀerences between
best performing methods are small, our results suggest using either
ANTs, Elastix or NiftyReg to determine hippocampal atrophy rates.
Since the diﬀerences between those methods are fairly small, the pre-
ferred method would mostly depend on computational eﬃciency.
The conclusions above are also reﬂected in the colour coded dis-
tance matrix, where one can observe that the registration-based
methods, including MALF and FreeSurfer, agree best with each other.
Within those, Elastix, MIRTK and NiftyReg had smallest average dis-
tances ranging from 1.1% to 1.7%, possibly reﬂecting that these are
based on the same underlying principle (FFD). Comparing ANTs to
these methods yielded average distances ranging from 2.2% to 2.9%.
In the validation dataset we deformed manual BL segmentations
with ANTs to determine hippocampal atrophy rates. But we also
showed that when replacing manual BL segmentation by MALF or FSL-
FIRST segmentation in the validation dataset, atrophy rates were hardly
aﬀected (supplementary ﬁg. 2 and 3), showing that the accuracy of the
BL segmentations is not vital for the outcome of non-linear methods.
Therefore, methods to measure hippocampal atrophy rates that are
based non-linear registration methods can be completely automated by
supplying an automatic BL segmentation. Such a procedure is similar to
FreeSurfer's longitudinal pipeline, in which images are ﬁrst pre-pro-
cessed (resampling, skull stripping, intensity normalization), then an
unbiased atlas registration procedure is used and ﬁnally labels from
diﬀerent time-points are fused (Reuter et al., 2012, 2010; Reuter and
Fischl, 2011).
Of all automatic segmentation methods (FSL-FIRST, MALF and
FreeSurfer), FreeSurfer performed best. We used FreeSurfer v6.0 and
compared to other studies in which v5.3 was used [Cover et al., 2016;
Mulder et al., 2014], FreeSurfer clearly improved and atrophy rates
were well reproduced in comparison with the other methods (4th
lowest of all methods; DAve= 3.26%). It is important to note again that
diﬀerent software may select diﬀerent parts of the hippocampus, and
some may even in some cases include other tissues. It will be important
for future studies to investigate this heterogeneity and establish har-
monized protocols, such as HarP (http://www.hippocampal-protocol.
net/), for the assessment and reparation of errors.
Somewhat surprisingly given the previous good performance of
Multiple-Atlas Propagation and Segmentation with Hippocampal
Boundary Shift Integral (MAPS-HBSI) in [Cover et al., 2016] is the poor
performance of the multi-atlas method MALF. This discrepancy could
be due to the fact that the registration used in our implementation of
MALF was fast but not maximally optimized, and to the fact that MAPS-
HBSI included a boundary shift integral calculation to compute volume
change, whereas in this paper only the BL and FU cross-sectional seg-
mentations were used to calculate volume change. Furthermore, dif-
ferent label fusion techniques might improve results for multi-atlas
segmentation methods as for example in [Song et al., 2017; Zhu et al.,
2017].
Manual segmentation was performed on resliced MRI with 2mm
slices. Supplementary ﬁg. 3 and the corresponding analysis illustrated
that this reslicing did not have a large inﬂuence in our analysis, because
MALF was performed on native MR image resolution. The low re-
producibility of manually measured atrophy rates was to some extent
surprising, because hippocampus segmentations of the A and B scans
showed high outline reproducibility (Jaccard~0.8 equivalent to a
Dice~0.89 and ICC for absolute agreement of 0.98) as found in a pre-
vious study using the same manual segmentations [Bartel et al., 2017].
Apparently, such small diﬀerences in outlines with uncorrelated errors
result in large uncertainties in volume. The reason why non-linear re-
gistration-based methods are more accurate is that registrations work at
sub-pixel level, whereas manual segmentations are outlined pixel-by-
pixel and contain therefore more noise. This noise is enhanced in the
relative diﬀerence, making manual segmentation a poor choice for
measuring atrophy rates.
Even in elderly healthy aging subjects, hippocampal atrophy is to be
expected [Fraser et al., 2015]. However, in all groups (CTRL, MCI and
AD) and for all methods we also measured unexpected hippocampal
volume increase for a few subjects (Fig. 3). Unexpected hippocampal
volume increase for a few subjects can also be observed in other studies
in which hippocampal atrophy rates were measured [Cover et al., 2016;
Mulder et al., 2014; van de Pol et al., 2007a; Yushkevich et al., 2010].
We did not further investigate these subjects with positive PVCs, but
most probably they are due to noise in the images.
Each registration method might be improved by adjusting regis-
tration parameters. We used the training dataset and changed para-
meters until we measured similar group-based atrophy rates for each
method. A larger investigation to obtain optimal registration para-
meters would be preferable but is also challenging because a ground
truth does not exist, since manual segmentations are not reliable en-
ough.
Except of brain extraction to reduce image registration time, we did
not include any other image pre-processing steps. Intensity normal-
ization might improve results for all non-linear registration methods. In
FreeSurfer's pipeline intensity normalization is already included.
Further improvements may be achieved by removing directional re-
gistration bias during the global/rigid registration step and by applying
a symmetric global/rigid registration as discussed and investigated in
[Modat et al., 2014; Yushkevich et al., 2010].
4.1. Clinical applicability
Our ﬁndings are of interest for clinical trials enrolling MCI and AD
subjects to aim for a treatment in earlier parts of the disease process. In
such trials hippocampal volume change plays a role in the inclusion and
exclusion criteria and is an important secondary outcome measure
(Albert et al., 2011; Dubois et al., 2014; Hill et al., 2014). We de-
termined consistent methods, for which low sample sizes of approxi-
mately 15–35 subjects are needed to determine a signiﬁcant diﬀerence
between CTRL and AD subjects. Because the volume change diﬀerence
between CTRL and MCI subjects is smaller, many more subjects are
needed for such trials. However, compared to manually determined
hippocampal volume change, for the most consistent methods, such as
ANTs, Elastix and NiftyReg, 64%, 50% and 57% less samples are needed
respectively.
Furthermore, we believe that our ﬁndings have potential clinical
applicability in radiotherapy, where hippocampal volume loss has re-
cently become a point of concern when patients are given prophylactic
cranial irradiation (PCI). In a recent study, longitudinal brain changes
were reported in 22 patients with SCLC received PCI using the SPM
software package (http://www.ﬁl.ion.ucl.ac.uk/spm/) [Simó et al.,
2016]. There, hippocampal volume decrease was associated with PCI,
but the magnitude of hippocampal volume loss was not reported. In a
small case series study (n= 9) patients with melanoma brain metastasis
showed a mean hippocampal volume loss of 7.81% due to whole brain
irradiation therapy after 6month [Hong et al., 2017]. Additionally, in
patients with primary brain tumours dose was signiﬁcantly correlated
with hippocampal volume loss one year after radiotherapy, while high
doses of> 40Gy showed a mean hippocampal volume loss of 5.8% and
low doses of< 10Gy a mean volume loss of 1.2% [Seibert et al., 2017].
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These reported hippocampal volume losses exceed one-year hippo-
campal atrophy in AD of 2.5–3.5% as determined in this study. Hence,
we expect that radiation induced annual hippocampal volume loss
should be detectable with for instance ANTs, Elastix or NiftyReg even
with fairly small sample size (Table 4).
5. Conclusion
Hippocampal volume loss measured on longitudinal T1-weighted
MRI should preferably be computed with symmetric non-linear regis-
tration methods such as ANTs, Elastix or NiftyReg, because these were
least susceptible to noise. Such methods allow detecting the diﬀerence
in one-year atrophy between Alzheimer patients and healthy controls
with approximately 15–35 patients.
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